The Effects of Serotonin Receptor Type 7 Modulation on Bowel Sensitivity and Smooth Muscle Tone in Patients With Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a gut-brain disorder involving alterations in intestinal sensitivity and motility. Currently, IBS has no cure, and treatment focuses on the management of symptoms. The diverse, and sometimes contradictory, collections of symptoms reported across the different subtyp...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2023-07, Vol.15 (7), p.e42532-e42532
Main Authors: Osman, Usama, Latha Kumar, Abishek, Sadagopan, Aishwarya, Mahmoud, Anas, Begg, Maha, Tarhuni, Mawada, N. Fotso, Monique, Gonzalez, Natalie A, Sanivarapu, Raghavendra R
Format: Article
Language:English
Subjects:
Abdomen
Colorectal cancer
Constipation
Diarrhea
Disease
Family/General Practice
Gastroenterology
Internal Medicine
Intervention
Irritable bowel syndrome
Observational studies
Pain
Patients
Psychotherapy
Quality of life
Serotonin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Irritable bowel syndrome (IBS) is a gut-brain disorder involving alterations in intestinal sensitivity and motility. Currently, IBS has no cure, and treatment focuses on the management of symptoms. The diverse, and sometimes contradictory, collections of symptoms reported across the different subtypes of IBS make treatment, as well as diagnosis, difficult for physicians. All subtypes of IBS have one symptom in common: abdominal pain caused by differences in the level of visceral sensitivity. Though current research on this topic is in its infancy, some researchers have proven, through experimental studies, that 5-hydroxytryptamine (serotonin) receptor type 7 (5-HT7) affects both visceral sensitivity and smooth muscle tone in the bowel. Therefore, this review will be discussing the future possibility of alleviating abdominal pain in patients with IBS and related disorders by modulating the 5-HT7 receptor.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.42532